Evidence map›Paper›PMID 28642746›Full record

ArticleFrontiers in microbiology2017

Virucidal Activity of Fogged Chlorine Dioxide- and Hydrogen Peroxide-Based Disinfectants against Human Norovirus and Its Surrogate, Feline Calicivirus, on Hard-to-Reach Surfaces.

Naim Montazeri, Clyde Manuel, Eric Moorman, Janak R Khatiwada, Leonard L Williams, Lee-Ann Jaykus

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04343742 (Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04343742 unknown statusnot on this mapstarted 2020, after this paper: background citation

Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19

TypeobservationalSponsorGenesis FoundationRan2020 to 2020Enrolled20ConditionsCOVID-19Armschlorine dioxide 3000 ppm
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Naim MontazeriDepartment of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, RaleighNC, United States.
Clyde ManuelDepartment of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, RaleighNC, United States.
Eric MoormanDepartment of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, RaleighNC, United States.
Janak R KhatiwadaCenter for Excellence in Post-Harvest Technologies, North Carolina A&T State University, NC Research Campus, KannapolisNC, United States.
Leonard L WilliamsCenter for Excellence in Post-Harvest Technologies, North Carolina A&T State University, NC Research Campus, KannapolisNC, United States.
Lee-Ann JaykusDepartment of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, RaleighNC, United States.
North Carolina State University · USCenter for Excellence in Education · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human norovirus (NoV) is the leading cause of foodborne illnesses in the United States. Norovirus is shed in high numbers in the feces and vomitous of infected individuals. Contact surfaces contaminated with bodily fluids harboring infectious virus particles serve as vehicles for pathogen transmission. Environmental stability of NoV and its resistance to many conventional disinfectants necessitate effective inactivation strategies to control the spread of virus. We investigated the efficacy of two commercial disinfectants, hydrogen peroxide (7.5%) and a chlorine dioxide (0.2%)-surfactant-based product using a fogging delivery system against human NoV GI.6 and GII.4 Sydney strains as well as the cultivable surrogate, feline calicivirus (FCV) dried on stainless steel coupons. Log

Indexed as

chlorine dioxidefogged disinfectanthydrogen peroxidenorovirus inactivationpublic healthsurface disinfection

Identifiers

PMID28642746
PMCPMC5462988
OpenAlexW2622280473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.